Insider filings made public on Thursday showed concentrated buying by large shareholders and company executives alongside notable sell-side activity by significant holders and managers. Below is a company-by-company account of the most material disclosures, followed by a brief analysis of valuation signals and trading-plan context disclosed within the filings.
Material purchases
Globalharvest Holdings Venture Ltd, identified in regulatory paperwork as a 10% owner of Mission Produce, Inc. (NASDAQ:AVO), materially expanded its stake in the avocado distributor in early July. The investment vehicle purchased common stock totaling approximately $15.8 million across two days - July 7 and July 8, 2026 - at average prices between $13.40 and $13.42 per share. The filings indicate those buys occurred as the Mission Produce share price had recently shown momentum, having risen more than 8% over the prior week and 16% year-to-date, with the stock trading at $13.35.
A consortium of entities and an individual, all designated as 10% owners of Energizer Holdings, Inc. (NASDAQ:ENR), also executed purchases on July 7 and July 8, 2026. Collectively they acquired roughly $1.64 million of common stock in two transactions at weighted average prices ranging from $20.2458 to $20.8098. The filing provides more detail for the July 7 activity: 40,000 shares were acquired at a weighted average price of $20.8098, with individual transaction prices noted between $20.3938 and $21.19. Those purchases raised total direct ownership to 7,380,000 shares. The timing coincides with a stock that has slipped about 8% over the prior week and was trading at $20.21 when reported. The filing package includes InvestingPro commentary describing Energizer as appearing undervalued at current levels, trading at a low earnings multiple of 7.3 and offering a dividend yield approaching 6%.
At Energy Fuels Inc. (NYSE American:UUUU), Ross R. Bhappu - President and Chief Executive Officer - reported a sizeable acquisition of common stock. A Form 4 filed with the Securities and Exchange Commission shows Mr. Bhappu purchased 74,000 common shares on July 7, 2026, at an average price of $13.08 per share, for a total outlay of $967,920. The document notes the average price represents an aggregation of multiple buys executed the same day. That buy came while the company’s shares were trading at $13.49, a price point that followed a 141% gain over the past year and a 26% decline over the last six months.
Wrap Technologies, Inc. (NASDAQ:WRAP) disclosed a director-level purchase on July 8, 2026. John Shulman acquired 100,000 shares of the company’s common stock at $1.10 per share for a total of $110,000. After the purchase Mr. Shulman directly holds 199,037 shares. The filing also notes his association with Juggernaut Management, LLC, which indirectly holds 250,000 shares. As manager of Juggernaut Management, LLC, Mr. Shulman may be deemed to beneficially own those securities, though he disclaims ownership beyond his pecuniary interest. The timing of the director purchase is notable because the stock had surged about 67% over the prior week and was trading at $2.35 - more than double the $1.10 purchase price. InvestingPro commentary included in the reporting highlights that WRAP holds more cash than debt and has a "Fair" financial health score.
Douglas A. Virtue, Executive Vice President of Virco Mfg Corporation (NASDAQ:VIRC), reported two small purchases on July 8 and July 9, 2026. The transactions totaled $48,503, with shares bought at prices ranging from $5.997 to $6.00 per share. On July 8 Mr. Virtue acquired 8,083 shares and added 5 more shares on July 9.
Large dispositions
Insight Holdings Group, LLC and several affiliated investment funds, each classified as ten percent owners, sold a combined 426,171 shares of Hinge Health, Inc. (NASDAQ:HNGE) Class A Common Stock across two trading days in July for roughly $38,446,957. The sales took place on July 7 and July 9, 2026. On July 7 the entities sold 244,672 shares at a weighted average price of $90.2263 per share in multiple transactions with prices reported between $90.00 and $90.645. The filings come as Hinge Health shares trade near a 52-week high of $91.07 after a 104% return over the past year. The materials accompanying the filing reference InvestingPro analysis that places the stock above its Fair Value estimate and categorizes it among the most overvalued names in the market.
CoreWeave, Inc. (NASDAQ:CRWV) disclosed a significant set of sales executed by its CEO and related entities on July 7 and July 8, 2026. Michael N. Intrator sold a total of 369,489 shares of Class A Common Stock for about $30.8 million. Those sales were carried out under a Rule 10b5-1 trading plan that Mr. Intrator adopted on November 20, 2025. Weighted average prices for the sold shares ranged from $80.2008 to $89.8808. Specifically, on July 7 Mr. Intrator directly sold 200,000 shares in multiple transactions at prices from $79.61 to $85.20. On the same day Omnadora Capital LLC - an entity for which Mr. Intrator is the sole manager of its manager and may be deemed a beneficial owner - sold 107,692 shares in multiple transactions at prices within the same $79.61 to $85.20 band. The filings note that the stock had posted an approximate 10% gain over the preceding week and was trading at $89.70. InvestingPro commentary included with the disclosures warns that the company is "quickly burning through cash," identified as one of 14 ProTips available to subscribers.
Samsara Inc. (NASDAQ:IOT) reported sales by two executive officers under pre-arranged plans. Sanjit Biswas, Chief Executive Officer, sold 263,900 shares of Class A Common Stock across July 7 and July 8, 2026, receiving approximately $9.67 million at prices ranging from $35.0423 to $38.3489 per share. The sales were executed under a Rule 10b5-1 plan adopted on September 29, 2025. John Bicket, Executive Vice President and Chief Technology Officer at Samsara, also sold roughly $9.67 million of Class A Common Stock on July 7 and July 8, 2026, with sale prices ranging from $35.0279 to $38.3473 per share. Both executives’ transactions were conducted pursuant to pre-arranged 10b5-1 plans. Samsara shares were trading at $36.99 at the time of reporting, giving the company a market capitalization of $21.23 billion. InvestingPro analysis cited in the filings states that Samsara appears overvalued versus its Fair Value assessment.
Kimberly A. Fields, Chair, President and Chief Executive Officer of ATI INC (NYSE:ATI), sold 40,000 shares of company common stock on July 7, 2026. Those transactions totaled roughly $7.32 million and were executed at prices ranging from $179.25 to $187.50 per share. The filings indicate these sales were undertaken pursuant to a 10b5-1 trading plan Ms. Fields established on February 5, 2026 for personal tax and estate planning reasons.
Contextual notes and takeaways
The filings present a mix of deliberate accumulation by large shareholders and purchases by executives alongside planned dispositions and sales by sizeable holders. Some buy transactions were filed by entities that hold ten percent positions; others were direct purchases by officers and directors. On the sell side, a number of the largest moves were executed under Rule 10b5-1 trading plans established prior to the reported sales, a detail the disclosures emphasize.
Several filings included valuation commentary from InvestingPro. That commentary characterized Energizer as appearing undervalued based on a low earnings multiple of 7.3 and a near-6% dividend yield, while it flagged Hinge Health and Samsara as currently trading above their Fair Value estimates. CoreWeave was highlighted for rapid cash burn in the InvestingPro notes attached to the filings.
Regulatory paperwork shows insiders sell for a broad set of reasons - the filings and standard market disclaimers remind readers this can include diversification, tax planning, and routine personal financial decisions - and several of the reported sales were executed through pre-arranged plans designed to avoid timing questions under trading rules.
Detailed holdings and pricing
- Mission Produce - Globalharvest Holdings Venture Ltd increased its stake by buying roughly $15.8 million of stock on July 7 and July 8, 2026, at average prices between $13.40 and $13.42; shares trading at $13.35.
- Energizer - 10% owners collectively purchased about $1.64 million of stock across July 7-8, 2026; weighted average prices ranged from $20.2458 to $20.8098; shares trading at $20.21.
- Energy Fuels - CEO Ross R. Bhappu bought 74,000 shares on July 7, 2026, at an average price of $13.08 for $967,920; shares trading at $13.49.
- Wrap Technologies - Director John Shulman bought 100,000 shares on July 8, 2026, at $1.10 per share for $110,000; direct holdings now 199,037 shares; stock trading at $2.35.
- Virco Mfg - EVP Douglas A. Virtue bought shares on July 8 and July 9, 2026, totaling $48,503 at prices between $5.997 and $6.00 per share.
- Hinge Health - Insight Holdings Group, LLC and affiliates sold 426,171 Class A shares on July 7 and July 9, 2026, for about $38,446,957; July 7 sales included 244,672 shares at a weighted average price of $90.2263; shares trading near $91.07.
- CoreWeave - CEO Michael N. Intrator sold 369,489 Class A shares on July 7 and July 8, 2026, for approximately $30.8 million under a 10b5-1 plan; weighted average sale prices ranged from $80.2008 to $89.8808; shares trading at $89.70.
- Samsara - Sanjit Biswas and John Bicket sold a combined set of shares on July 7-8, 2026, totaling 263,900 shares for Mr. Biswas and a comparable $9.67 million position for Mr. Bicket; prices ranged roughly from $35.02 to $38.35; shares trading at $36.99.
- ATI - Kimberly A. Fields sold 40,000 shares on July 7, 2026, for about $7.32 million at prices from $179.25 to $187.50 per share.
Investor considerations
The disclosed activity reinforces that insider trading disclosures can reflect a wide array of motivations. While insider purchases are commonly interpreted as signals of management or major-holder confidence, and sales may be viewed as a lack of confidence, the filings explicitly note many sales result from pre-arranged plans or routine personal financial planning. Investors should therefore incorporate these transactions into a broader analysis rather than treating them as sole investment signals.
Where filings include third-party valuation commentary, such as the InvestingPro notes accompanying several of these disclosures, investors will often weigh those perspectives alongside company-specific fundamentals and their own risk tolerance.